Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
about
Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patientsPredictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachMathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.Mathematical Modeling Predicts that Increased HSV-2 Shedding in HIV-1 Infected Persons Is Due to Poor Immunologic Control in Ganglia and Genital MucosaHerpes simplex virus-2 transmission probability estimates based on quantity of viral sheddingHerpes simplex virus-2 genital tract shedding is not predictable over months or years in infected persons.Rabbit and mouse models of HSV-1 latency, reactivation, and recurrent eye diseasesHSV-1 latent rabbits shed viral DNA into their saliva.Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovirRapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tractMucosal HSV-2 Specific CD8+ T-Cells Represent Containment of Prior Viral Shedding Rather than a Correlate of Future Protection.Silicone-acyclovir controlled release devices suppress primary herpes simplex virus-2 and varicella zoster virus infections in vitroRapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.Rapid host immune response and viral dynamics in herpes simplex virus-2 infection.A Fixed Spatial Structure of CD8 T Cells in Tissue during Chronic HSV-2 Infection
P2860
Q24194490-DDC29A02-BE19-49FD-8DB2-761C334F9C83Q27324340-5B315789-A105-42C4-882C-7DDAB6CF434CQ27324453-E6A8CB3F-74F6-4EB5-BBD0-D02FD609AB26Q27347896-11C95491-E914-4A6B-9064-33C8562500CDQ28236882-E4ED2B02-F2A5-4C67-979F-FDB230E388C5Q34464387-C87BC656-F61C-4886-8903-7DA2ABCC145FQ36307684-B9572D84-27D7-4F81-B17B-61556EEA3D5FQ36459433-8AAA73E2-C204-4F99-830C-5DF26DC79731Q36509679-950C1DA6-1003-4679-A950-C9B62472521DQ36776541-0A4B9DB4-8B83-4E14-8146-CC030B0B0E85Q37051012-DE2B4D40-2928-40EB-BC71-7E7793D8B971Q37105722-57494D5D-ADEA-49F1-9C60-980DA16B3AA1Q37335794-0BA02FE4-88FF-419D-B95F-7C0C688B8818Q37694574-A85B10AD-1399-4C98-B149-4F98112AF51CQ57269664-18FB5147-F5B1-45E5-93EF-CA57AC832CD0
P2860
Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Detailed analysis of mucosal h ...... and without antiviral therapy.
@ast
Detailed analysis of mucosal h ...... and without antiviral therapy.
@en
type
label
Detailed analysis of mucosal h ...... and without antiviral therapy.
@ast
Detailed analysis of mucosal h ...... and without antiviral therapy.
@en
prefLabel
Detailed analysis of mucosal h ...... and without antiviral therapy.
@ast
Detailed analysis of mucosal h ...... and without antiviral therapy.
@en
P2093
P2860
P356
P1476
Detailed analysis of mucosal h ...... and without antiviral therapy.
@en
P2093
Amalia Magaret
Joshua T Schiffer
Stacy Selke
P2860
P304
P356
10.1093/JAC/DKR346
P407
P577
2011-08-24T00:00:00Z